Max Healthcare Announces Organizational Changes

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2011 /PRNewswire/ -- Max Healthcare, India's first comprehensive provider of standardized, seamless and world-class healthcare services, today announced organizational changes that include Dr. Ajay Bakshi joining the Company as Chief Executive Officer, effective November 1, 2011. The Company also named Dr. Abha Aggarwal to the position of Chief Operating Officer and announced that Mr. Ranvir Bhandari would be taking the additional role of Chief Service Officer.

(Logo:  http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

Commenting on the new appointments, Max Healthcare Managing Director Rahul Khosla said: "In today's world it is very important to harness and leverage on a mixture of different domain expertise." Instead of having one person who takes every decision, the company wants accountability to be clear but the process of making decisions should invite as much expertise as possible. 

Prior to his new assignment, Dr. Bakshi was as an associate principal with McKinsey & Company. Dr. Agrawal served as the Chief Medical Officer and Chief Informatics Officer at Kings County Hospital Centre in New York. 

Mr. Analjit Singh, founder of the Max Group, said that he strongly believes the new leadership team at Max Healthcare will bring in the youth and vigor needed to successfully run and grow a large healthcare business.  He looks forward to a progressive new phase in Max Healthcare's revolution towards becoming India's most admired healthcare providers.

About Max Healthcare

With over 1100 beds, 12 hospitals, 1500 physicians and 3000 support staff - Max Healthcare is one of a leading chain of hospitals in India. Its state of the art infrastructure, over 275 ICU beds and most advanced technologies makes it one of the best hospitals in India.  For more information please visit www.maxhealthcare.in.  

About Max Neeman International

Max Neeman International is a leading India CRO offering services for the successful conduct of Phase II-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 & ISO 27001:2005 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 31 cities with 6 regional offices. For more information please visit www.neeman-medical.com.

SOURCE Max Neeman International